View in EDS HTML Full Text PDF Full Text

Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.

Saved in:
Bibliographic Details
Title: Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.
Authors: García-Romero, N.1,2 (AUTHOR), Palacín-Aliana, I.1,3 (AUTHOR), Madurga, R.1,2 (AUTHOR), Carrión-Navarro, J.2,4,5 (AUTHOR), Esteban-Rubio, S.6 (AUTHOR), Jiménez, B.1 (AUTHOR), Collazo, A.1 (AUTHOR), Pérez-Rodríguez, F.1 (AUTHOR), Ortiz de Mendivil, A.1 (AUTHOR), Fernández-Carballal, C.7 (AUTHOR), García-Duque, S.1 (AUTHOR), Diamantopoulos-Fernández, J.1 (AUTHOR), Belda-Iniesta, C.1 (AUTHOR), Prat-Acín, R.8 (AUTHOR), Sánchez-Gómez, P.9 (AUTHOR), Calvo, E.1,10 (AUTHOR), Ayuso-Sacido, A.2,4,5,6 (AUTHOR) ayusosacido@gmail.com
Source: BMC Medicine. 6/22/2020, Vol. 18 Issue 1, p1-16. 16p. 2 Diagrams, 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17417015
DOI:10.1186/s12916-020-01610-0